What an impactful performance on increase in Revenue.. ! A lesson probably many biotech as well as companies in general to learn on how an appoint of a CEO with right education and work experience makes change to the future of the company (Sigma is another example).
Education in Pharmaceutical science which is the core of the industry PNV works and MBA which helps one learn sales, marketing, operations & finance combined with J&J work history in three different country !
Most Biotech & Medical device companies run by accountant and lawyers on the board (+ HC stock pumpers !) with pathetic promises of performance but no delivery and capital raise every now and then with no tangible results apart form we going phase xx to xxx !
Ann: FY24 Trading Result (unaudited), page-95
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.49 |
Change
-0.120(4.60%) |
Mkt cap ! $1.718B | |||
| Open | High | Low | Value | Volume |
| $2.69 | $2.74 | $2.49 | $5.988M | 2.290M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 38045 | $2.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.51 | 27863 | 3 |
View Market Depth
| Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |